chr10-132538125-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005539.5(INPP5A):c.29C>T(p.Thr10Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000879 in 1,252,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005539.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
INPP5A | NM_005539.5 | c.29C>T | p.Thr10Ile | missense_variant | 1/16 | ENST00000368594.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
INPP5A | ENST00000368594.8 | c.29C>T | p.Thr10Ile | missense_variant | 1/16 | 1 | NM_005539.5 | P1 | |
INPP5A | ENST00000368593.7 | c.29C>T | p.Thr10Ile | missense_variant | 1/13 | 1 | |||
INPP5A | ENST00000423490.5 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151574Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000727 AC: 8AN: 1100512Hom.: 0 Cov.: 30 AF XY: 0.00000762 AC XY: 4AN XY: 524954
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151574Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74006
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.29C>T (p.T10I) alteration is located in exon 1 (coding exon 1) of the INPP5A gene. This alteration results from a C to T substitution at nucleotide position 29, causing the threonine (T) at amino acid position 10 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at